XML 31 R17.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
9. Income Taxes

For the years ended December 31, 2025, 2024, and 2023, our income (loss) before income taxes was comprised of the following (in thousands):

Year Ended December 31,
202520242023
Domestic$(17,496)$(55,183)$(89,925)
Foreign23,940 (36,025)(18,307)
Total$6,444 $(91,208)$(108,232)
For the years ended December 31, 2025, 2024, and 2023, our income tax expense was comprised of the following (in thousands):
Year Ended December 31,
202520242023
Current:
Federal$22 $(10)$34 
State171 149 223 
Foreign5,360 1,864 4,523 
Total current expense5,553 2,003 4,780 
Deferred:
Federal— — — 
State— — — 
Foreign(342)(949)(1,571)
Total deferred benefit(342)(949)(1,571)
Total income tax expense$5,211 $1,054 $3,209 

For the year ended December 31, 2025, the provision for income taxes differs from the amount computed by applying the federal statutory income tax rates to our income before the provision for income taxes as follows:

Year Ended December 31, 2025
Total
%
U.S. federal statutory tax rate
$1,353 21.0 %
State income taxes, net of federal income tax effect(1)
171 2.7 
Foreign tax effects
Switzerland
Statutory income tax rate differential(1,193)(18.5)
Net operating loss expiration2,185 33.9 
Unrealized currency translation gain
1,873 29.1 
Changes in valuation allowances
(5,039)(78.2)
Other
199 3.1 
Other foreign jurisdictions
2,008 31.2 
Effect of cross-border tax laws
Global intangible low-taxed income
(2,283)(35.4)
Other
33 0.5 
Tax credits
Research & development tax credits
(3,991)(61.9)
Changes in valuation allowances
5,937 92.1 
Non-taxable or Non-deductible Items
Share-based compensation
2,999 46.5 
Other
937 14.5 
Changes to unrecognized tax benefits
22 0.3 
Total tax provision and effective tax rate
$5,211 80.9 %
(1) State taxes in Texas primarily make up this category. The largest state by apportionment percentage is Virginia.
For the years ended December 31, 2024 and 2023, the provision for income taxes differs from the amount computed by applying the federal statutory income tax rates to our income before the provision for income taxes as follows:

Percentage of Pretax Earnings
20242023
U.S. federal statutory tax rate21.0 %21.0 %
State tax expense
4.3 3.8 
Foreign rate differential
(4.0)(3.1)
Nondeductible expenses
(1.0)(0.7)
Foreign tax expense
0.1 (0.4)
Equity compensation
3.7 (2.4)
Tax credits7.3 9.5 
Unrecognized tax benefits
(1.5)(1.8)
Global intangible low-taxed income
(3.0)— 
Change in tax rate
0.8 (0.9)
Other
(0.5)0.2 
Return to provision
3.3 — 
Deferred adjustments
(1.4)(3.0)
Change in valuation allowance
(30.3)(25.2)
Total
(1.2)%(3.0)%

The 2025 effective tax rate of 80.9% is detailed in the above table. The effective tax rate is driven by jurisdictional profitability mix; specifically, tax losses in the U.S. and Switzerland provided no tax benefit, while profits in other international jurisdictions remained subject to tax. In 2024, the effective tax rate of (1.2)% included $27.6 million of tax expense attributable to the change in the valuation allowances in the United States and Switzerland, partially offset by $6.7 million of favorable tax benefits for research credits. In 2023, the effective tax rate of (3.0)% included $27.3 million of tax expense attributable to the change in the valuation allowances in the United States and Switzerland, partially offset by $10.3 million of favorable tax benefits for research credits.
Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amount of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
As of December 31, 2025 and 2024, significant components of our deferred tax assets and liabilities were as follows (in thousands):

As of December 31,
20252024
Deferred tax assets:
Net operating losses$114,153 $107,170 
Tax credits39,002 34,885 
Deferred revenue310 521 
Equity compensation5,024 3,994 
Lease liabilities16,138 17,465 
Accrued compensation5,864 3,225 
Bad debt598 502 
Other accrued expense663 318 
Capitalized research and development costs36,186 45,820 
Other3,855 4,033 
Gross deferred tax assets221,793 217,933 
Less: Valuation allowance(191,198)(187,969)
Total deferred tax assets30,595 29,964 
Deferred tax liabilities:
Prepaid expenses(11,518)(13,298)
Right-of-use assets(7,809)(8,406)
Depreciation(2,363)(3,245)
Intangible assets(380)(688)
Other(3,675)(198)
Total deferred tax liabilities(25,745)(25,835)
Net deferred tax assets$4,850 $4,129 

As of December 31, 2025 and 2024, we had $325.6 million and $287.5 million, respectively, of gross net operating loss (“NOL”) carryforwards for U.S. federal tax purposes. U.S. federal NOL carryforwards in the gross amount of $23.5 million and generated prior to 2018 will expire, if unused, in 2037. Under the Tax Cuts and Jobs Act of 2017 (the “TCJA”), as modified by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), federal NOL carryforwards generated in tax years beginning after December 31, 2017 may be carried forward indefinitely. As of December 31, 2025, we had $302.1 million of gross NOL carryforwards generated after 2017 for U.S. federal tax purposes, which may be used to offset up to 80% of our taxable income annually.

Section 382 of the Internal Revenue Code limits the utilization of NOL carryforwards when ownership changes occur, as defined by that section. A number of states have similar laws that limit utilization of state NOL carryforwards when ownership changes occur. We have performed an analysis of our Section 382 ownership changes and determined all U.S. federal and state NOL carryforwards are available for use as of December 31, 2025.

As of December 31, 2025 and 2024, we had $36.5 million and $32.5 million, respectively, of U.S. federal tax credit carryforwards which will expire, if unused, between 2031 and 2045.

As of December 31, 2025 and 2024, we had U.S. gross state NOL carryforwards of $325.6 million and $297.5 million, respectively. We had tax-effected state NOL carryforwards of $17.1 million and $17.8 million as of
December 31, 2025 and 2024, respectively. The rules regarding carryforwards vary from state to state, and the ability to utilize NOLs varies based on timing and amount. The majority of state NOL carryforwards generated prior to 2018 will expire, if unused, in 2037. Due to the TCJA, certain state NOL carryforwards generated after 2017 have an indefinite carryforward period.

As of December 31, 2025 and 2024, we had foreign gross NOL carryforwards of $231.6 million and $230.1 million, respectively, primarily attributable to our subsidiary in Switzerland. We had tax-effected foreign NOL carryforwards of $28.7 million and $29.0 million as of December 31, 2025 and 2024, respectively. In 2025, $3.0 million of tax-effected Swiss NOLs expired related to the 2018 tax year. An additional portion of those NOL carryforwards will expire each year, if unused, between 2026 and 2032.

As of December 31, 2025 and 2024 we had a total valuation allowance of $191.2 million and $188.0 million, respectively. The following table summarizes the activity related to our valuation allowances for the years ended December 31, 2025, 2024, and 2023 (in thousands):

Year Ended December 31,
202520242023
Beginning balance
$187,969 $161,966 $132,581 
Charged to expense
(437)27,605 27,267 
Foreign currency translation adjustments
3,666 (1,602)2,118 
Deductions from reserve
— — — 
Ending balance
$191,198 $187,969 $161,966 

As of December 31, 2025, we continued to maintain a full valuation allowance against U.S. deferred tax assets based on our cumulative operating results as of December 31, 2025, three-year cumulative loss, and an assessment of our expected future results of operations. We have evaluated all evidence, both positive and negative, in assessing the likelihood of realizability, and we determined the negative evidence outweighed the positive evidence.

As of December 31, 2025, we have a valuation allowance of $22.6 million against foreign deferred tax assets at our subsidiary in Switzerland. Based on our cumulative operating results as of December 31, 2025 and an assessment of expected future results of operations, we determined it was not more likely than not we would be able to realize the deferred tax assets prior to expiration.

We plan to distribute previously undistributed earnings of our foreign subsidiaries back to the United States in future years. Upon repatriation of those earnings, if any, we may be subject to taxes, including withholding taxes, net of any applicable foreign tax credits. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable.
For the years ended December 31, 2025, 2024, and 2023, cash paid, net of refunds received, consisted of the following:

Year Ended December 31,
202520242023
Federal
$— $— $— 
Aggregated state and local jurisdictions(1)
162 115 154 
Disaggregated foreign jurisdictions:
Australia829 298 664 
Canada389 84 447 
India524 766 212 
Italy684 359 586 
Mexico
31 204 162 
Netherlands
41 237 162 
Spain670 263 567 
United Kingdom
1,666 798 835 
Other(1)
124 210 210 
Net cash paid for income taxes
5,120 3,334 3,999 
[1] No jurisdictions are individually above the threshold of 5% of total income taxes paid, net of refunds received, for the periods presented.

As of December 31, 2025 and 2024, we had unrecognized tax benefits of $8.8 million and $7.8 million, respectively, none of which would affect our effective tax rate if recognized due to the valuation allowance. The following table summarizes the activity related to our unrecognized tax benefit from December 31, 2022 to December 31, 2025 (in thousands):

Balance as of December 31, 2022
$4,488 
Additions for tax positions in current years 1,740 
Additions for tax positions in prior years 256 
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2023
6,484 
Additions for tax positions in current years 1,374 
Reductions for tax positions in prior years
(18)
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2024
7,840 
Additions for tax positions in current years 1,001 
Additions for tax positions in prior years
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2025
$8,848 

We recognize interest and penalties related to uncertain tax positions in income tax expense. Our uncertain tax positions primarily relate to U.S. federal research and development tax credits. During the years ended December 31, 2025, 2024, and 2023, we recognized nominal amounts in interest. The cumulative balances of interest and penalties as of December 31, 2025 and 2024 were immaterial.
We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. Due to NOL carryforwards, tax years 2016 through 2025 remain open to examination by the major taxing jurisdictions to which we are subject. There are no open examinations that would have a meaningful impact to our consolidated financial statements.
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted, which extends most expiring TCJA provisions and reforms certain international tax rules. The application of the OBBBA to the Company did not have a material impact on its financial statements during the year ended December 31, 2025.